DexCom
DXCM
904 hedge funds and large institutions have $42.9B invested in DexCom in 2023 Q1 according to their latest regulatory filings, with 91 funds opening new positions, 342 increasing their positions, 345 reducing their positions, and 92 closing their positions.
3% more capital invested
Capital invested by funds: $41.8B → $42.9B (+$1.13B)
0.11% less ownership
Funds ownership: 95.68% → 95.57% (-0.11%)
1% less repeat investments, than reductions
Existing positions increased: 342 | Existing positions reduced: 345
1% less first-time investments, than exits
New positions opened: 91 | Existing positions closed: 92
3% less call options, than puts
Call options by funds: $465M | Put options by funds: $478M
2% less funds holding
Funds holding: 920 → 904 (-16)
31% less funds holding in top 10
Funds holding in top 10: 26 → 18 (-8)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Marshall Wace
London,
United Kingdom
|
+$221M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$202M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
+$152M |
| 4 |
Invesco
Atlanta,
Georgia
|
+$94.5M |
| 5 |
American Century Companies
Kansas City,
Missouri
|
+$91.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jennison Associates
New York
|
-$215M |
| 2 |
Janus Henderson Group
London,
United Kingdom
|
-$212M |
| 3 |
Sands Capital Management
Arlington,
Virginia
|
-$199M |
| 4 |
Millennium Management
New York
|
-$136M |
| 5 |
VOYA Investment Management
Atlanta,
Georgia
|
-$93.6M |
DXCM Hedge Fund Activity: Q1 2023 in Review
904 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in DexCom (DXCM) for Q1 2023, worth a combined $42.9B — up 2.7% from $41.8B a quarter earlier.
Sellers outnumbered buyers: 92 funds closed out of DXCM and 91 opened new positions — a net loss of 1 holder — while 345 trimmed existing stakes and 342 added.
The largest buyer was Marshall Wace, adding an estimated $221M. The largest seller was Jennison Associates, cutting an estimated $215M.
- 904 institutional investors held DexCom (DXCM) as of Q1 2023, down from 920 in Q4 2022.
- Funds reported $42.9B of DexCom stock for Q1 2023, up 2.7% quarter-over-quarter.
- 91 funds opened new DexCom positions in Q1 2023 and 92 closed out, a net change of -1 holder.
- The largest DexCom buyer in Q1 2023 was Marshall Wace, an estimated $221M added.
- The largest DexCom seller in Q1 2023 was Jennison Associates, an estimated $215M sold.
Based on aggregated 13F filings for Q1 2023.